header logo Pharma Manufacturing

The drug industry's voice for manufacturing excellence

  • Production
  • Development
  • Information Technology
  • Compliance
  • Quality & Risk
Pharma Manufacturing mega-logo
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg

Editors' (re)View

editreview
Editors' (re)View

Editor’s (re)View: Novo Nordisk knew what it was getting in purchase of troubled Indiana site

While the plant was recently hit with the FDA’s most severe post-inspection classification, it is a facility that has been plagued with problems for several years.
Oct. 17, 2025
editreview
Editors' (re)View

Editor’s (re)View: Cell and gene therapy sector regroups amid tough 2025

Oct. 10, 2025
editreview
Editors' (re)View

Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old

Oct. 3, 2025
editreview
Editors' (re)View

Editor’s (re)View: North Carolina’s biomanufacturing building boom is also a challenge

Sept. 26, 2025
editreview
Editors' (re)View

Editor’s (re)View: Novo Nordisk isn’t pandering to Trump with US manufacturing pledge

Sept. 19, 2025
editreview
Editors' (re)View

Editor’s (re)View: Not a good week for India’s Sun Pharma and API manufacturer Hikal

Sept. 12, 2025
editreview
Editors' (re)View

Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers

Sept. 5, 2025
editreview
Editors' (re)View

Editor’s (re)View: Watch out China, India’s CRDMOs have you in their crosshairs

Aug. 29, 2025
editreview
Editors' (re)View

Editor’s (re)View: What J&J’s $2B US manufacturing investment says about Trump’s tariff-driven onshoring strategy

Aug. 22, 2025

Looking for Something?

footer logo Pharma Manufacturing
Helping drugmarkers leverage technology and best practices to bring new therapies to market at scale—quickly, safely and efficiently
Newsletters
The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.
Connect
Follow us for the latest industry news and insights.
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
  • About Us
  • Advertise
  • Do Not Sell or Share
  • Privacy Policy
  • Terms & Conditions
EndeavorB2B Logo
© 2025 All rights reserved.